VT
Vislink Technologies, Inc. (VISL)·Q3 2019 Earnings Summary
Executive Summary
- Q3 revenue fell 40% YoY to $5.01M with gross margin compressing to 40.7%; diluted EPS was ($0.40). Management cited lingering supply chain issues that impeded bookings and shipments during the quarter .
- The balance sheet was de‑levered via a $12M equity raise in July; convertible debentures were fully repaid by Q3 end, though a small $0.23M note payable remained outstanding .
- Order momentum strengthened post‑quarter: $3M of new orders, a $13M backlog (+42% YoY), first deliveries on a $2.8M U.S. Army ISR receiver contract, and incremental public safety and international broadcast orders .
- No formal financial guidance was provided. Management emphasized ongoing supply-chain realignment, operational discipline, and leveraging growth verticals (military-government, live production, satcom) as potential stock catalysts .
What Went Well and What Went Wrong
What Went Well
- De‑leveraging and liquidity actions: July offering (~$12.0M gross) eliminated 2018 convertible debt; convertible notes were fully satisfied by Q3 end (debt discounts amortized to zero) .
- Order intake and backlog strength post‑quarter: $3M new orders and a ~$13M backlog (+42% YoY) across live production, mil‑gov, and satcom; first U.S. Army ISR contract delivery completed .
- Management quote: “We are confident that we are well‑positioned operationally to profitably build our order book, as we focus on pursuing new growth areas, as well as capturing the ongoing demand…” (CEO Roger Branton) .
What Went Wrong
- Top‑line and margin pressure: Q3 revenue down 40% YoY to $5.01M; gross margin fell to 40.7% from 49.2% in Q3’18, driven by supply‑chain disruptions affecting shipments .
- Losses widened: Operating loss ($4.90M) and net loss ($5.00M), with diluted EPS of ($0.40); G&A stayed elevated and FX losses were a headwind .
- Nasdaq compliance risk re‑emerged: Received a minimum-bid price deficiency notice on Sep 26, 2019; 180‑day cure period granted to Mar 24, 2020 .
Financial Results
Income statement summary – 2019 progression (oldest → newest)
Notes: Gross margin for Q1–Q2 calculated as (Revenue − Cost of components and personnel)/Revenue based on reported line items .
Q3 YoY and QoQ comparison; estimates
Estimates context: S&P Global consensus could not be retrieved via the tool at this time; as such, estimate comparisons are not available (see Estimates Context section).
Disaggregated revenue – Geography (Q3 only)
Disaggregated revenue – Revenue source (Q3 only)
KPIs and balance sheet items
Non‑GAAP: Company disclosed adjusted net loss of $3.8M and adjusted EBITDA loss of $2.9M for Q3 (reconciliations referenced in Corporate Update) .
Guidance Changes
Earnings Call Themes & Trends
Note: The company suspended traditional earnings calls in 2019, opting for written Corporate Updates; Q&A was not held in Q3 2019 .
Management Commentary
- Strategic focus and supply chain remediation: “This allowed the Company to de‑lever its balance sheet and be free of all funded debt for the first time. However, our performance was impeded… by lingering negative effects to our supply chain… investments we started making to realign the supply chain began to bear fruit.” — Roger Branton, CEO .
- Demand outlook: “We are gratified to see organic growth in our key verticals and a strong increase in our order backlog…” — John Payne, President & COO (Nov 6 orders update) .
Q&A Highlights
- No Q&A: The company did not hold an earnings call; it communicated via press release and corporate update, consistent with its August decision to forgo calls for cost and disclosure‑efficiency reasons .
Estimates Context
- Wall Street consensus (S&P Global) was not available via the tool at this time; therefore, we cannot provide beat/miss vs. consensus for revenue or EPS. Given VISL’s microcap profile and 2019 communication shift to written updates, formal sell‑side estimates appear limited; we default to reported GAAP and disclosed non‑GAAP metrics in this recap [Tool error on S&P Global estimates retrieval].
Key Takeaways for Investors
- Near‑term: Expect choppy reported results as supply‑chain realignment completes; watch for conversion of ~$13M backlog to revenue and margin stabilization back toward ~50% gross levels seen in 1H19 once shipment cadence normalizes .
- Balance sheet inflection: July capital raise removed high‑cost convertible overhang; focus shifts to working capital and execution (note a $0.23M note payable remains) .
- Demand signals: Post‑quarter orders across mil‑gov, public safety, and international broadcast, plus NATO BOA and Army ISR deliveries, corroborate pipeline health; order momentum is a potential upside catalyst if conversion is timely .
- Cost discipline sustained: R&D and opex reductions from 2018 restructuring persist; monitor for operating leverage as revenue recovers .
- Compliance/controls watch‑items: Renewed Nasdaq bid‑price deficiency and ongoing internal control weaknesses remain overhangs; ERP adoption and any corporate actions (e.g., split) to regain listing are key milestones .
- Trading setup: With estimate comparisons unavailable and limited coverage/liquidity, stock may be event‑driven around order announcements, large contract deliveries, and any capital markets actions or listing updates .